Skip to Content
Søg Menu

Post ASH: To danske studier perspektiverer nye behandlinger af lymfomer

I denne MEDtalk perspektiverer Simon Husby, læge, ph.d., Afd. for Blodsygdomme, Rigshospitalet, nye data for behandling af relapse/refraktær B-celle Non-Hodgkin lymfom og CHOP-lignende behandling ved nodal perifer T-celle lymfom.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Related

Carsten Niemann

Overlevelsesgevinst for skrøbelige CLL-patienter i behandling med Imbruvica og Venclyxto

/ Carsten Utoft Niemann
EHA23CLL Play the Video 3:35
Anna Sureda Balari

Epcoritamab with rituximab and lenalidomide (R2) for patients with high-risk follicular lymphoma

/ Anna Sureda Balari
EHA23Lymfom Play the Video 6:24
Mark Levis

Gilteritinib for patients with newly diagnosed AML

/ Mark Levis
EHA23Ernæring Play the Video 9:04
Arnon Kater

MURANO study supports the use of fixed-duration VenR in R/R CLL

/ Arnon Kater
EHA23CLL Play the Video 10:51
Evangelos Terpos

Daratumumab Combination Shows Positive Responses in Pretreated R/R Multiple Myeloma

/ Evangelos Terpos
EHA23Myelomatose Play the Video 6:39
Ryan Jacobs

News from EHA23 – A promising treatment option for follicular lymphoma

/ Ryan Jacobs
EHA23Lymfom Play the Video 11:56
Barbara Eichhorst

What is new from EHA23 regarding treatment Strategies in First-Line CLL?

/ Barbara Eichhorst
EHA23CLL Play the Video 3:19
Eva Futtrup Maksten

Risk of dementia in older patients treated with chemotherapy for lymphoma

/ Eva Futtrup Maksten
EHA23LymfomDemens Play the Video 03:17

Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

/ Evangelos Terpos / Jan Andreasen
EHA23Myelomatose
Back to top